Clinical Trial Update: A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating certolizumab pegol (Cimzia) in pregnant women with chronic inflammatory diseases has completed and posted results. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19